These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29170909)

  • 21. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.
    Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM
    J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer.
    Mohammad AS; Griffith JI; Adkins CE; Shah N; Sechrest E; Dolan EL; Terrell-Hall TB; Hendriks BS; Lee H; Lockman PR
    Pharm Res; 2018 Jan; 35(2):31. PubMed ID: 29368289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
    Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T
    Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver.
    Melancon MP; Yevich S; Avritscher R; Swigost A; Lu L; Tian L; Damasco JA; Dixon K; Cortes AC; Munoz NM; Liang D; Liu D; Tam AL
    Drug Deliv; 2021 Dec; 28(1):240-251. PubMed ID: 33501859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deformational changes after convection-enhanced delivery in the pediatric brainstem.
    Bander ED; Tizi K; Wembacher-Schroeder E; Thomson R; Donzelli M; Vasconcellos E; Souweidane MM
    Neurosurg Focus; 2020 Jan; 48(1):E3. PubMed ID: 31896089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model.
    Shi M; Fortin D; Paquette B; Sanche L
    Invest New Drugs; 2016 Jun; 34(3):269-76. PubMed ID: 26961906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEG-coated irinotecan cationic liposomes improve the therapeutic efficacy of breast cancer in animals.
    Zhang L; Cao DY; Wang J; Xiang B; Dun JN; Fang Y; Xue GQ
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3347-61. PubMed ID: 24379067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
    Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
    J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation.
    Dickinson PJ; LeCouteur RA; Higgins RJ; Bringas JR; Roberts B; Larson RF; Yamashita Y; Krauze M; Noble CO; Drummond D; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS
    J Neurosurg; 2008 May; 108(5):989-98. PubMed ID: 18447717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery.
    Mamot C; Nguyen JB; Pourdehnad M; Hadaczek P; Saito R; Bringas JR; Drummond DC; Hong K; Kirpotin DB; McKnight T; Berger MS; Park JW; Bankiewicz KS
    J Neurooncol; 2004 May; 68(1):1-9. PubMed ID: 15174514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin.
    Si J; Zhao X; Gao S; Huang D; Sui M
    Int J Pharm; 2019 Sep; 568():118499. PubMed ID: 31299338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canine spontaneous glioma: a translational model system for convection-enhanced delivery.
    Dickinson PJ; LeCouteur RA; Higgins RJ; Bringas JR; Larson RF; Yamashita Y; Krauze MT; Forsayeth J; Noble CO; Drummond DC; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS
    Neuro Oncol; 2010 Sep; 12(9):928-40. PubMed ID: 20488958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convection-enhanced delivery of sulfasalazine prolongs survival in a glioma stem cell brain tumor model.
    Haryu S; Saito R; Jia W; Shoji T; Mano Y; Sato A; Kanamori M; Sonoda Y; Sampetrean O; Saya H; Tominaga T
    J Neurooncol; 2018 Jan; 136(1):23-31. PubMed ID: 28929335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convection-enhanced delivery into the rat brainstem.
    Sandberg DI; Edgar MA; Souweidane MM
    J Neurosurg; 2002 May; 96(5):885-91. PubMed ID: 12005396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.
    Kikuchi T; Saito R; Sugiyama S; Yamashita Y; Kumabe T; Krauze M; Bankiewicz K; Tominaga T
    J Neurosurg; 2008 Nov; 109(5):867-73. PubMed ID: 18976076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excipient-free nanodispersion of 7-ethyl-10-hydroxycamptothecin exerts potent therapeutic effects against pancreatic cancer cell lines and patient-derived xenografts.
    Zhang L; Zhou J; Yan Y; Zhou X; Zhou Q; Du R; Hu S; Ge W; Huang Y; Xu H; Kong Y; Zheng H; Ding Y; Shen Y; Wang W
    Cancer Lett; 2019 Nov; 465():36-44. PubMed ID: 31479691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer.
    Leonard SC; Lee H; Gaddy DF; Klinz SG; Paz N; Kalra AV; Drummond DC; Chan DC; Bunn PA; Fitzgerald JB; Hendriks BS
    Anticancer Drugs; 2017 Nov; 28(10):1086-1096. PubMed ID: 28857767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled release of liposome-encapsulated temozolomide for brain tumour treatment by convection-enhanced delivery.
    Lin CY; Li RJ; Huang CY; Wei KC; Chen PY
    J Drug Target; 2018 Apr; 26(4):325-332. PubMed ID: 28911239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.
    Hashizume R; Ozawa T; Gryaznov SM; Bollen AW; Lamborn KR; Frey WH; Deen DF
    Neuro Oncol; 2008 Apr; 10(2):112-20. PubMed ID: 18287341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.